# Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT
Canonical URL: https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-update-on-the-commercial-launch-of-cardamysttm-etripamil-nasal-spray-for-the-treatment-of-psvt
Ticker: MIST
Company: Milestone Pharmaceuticals Inc.
Source: Milestone Pharmaceuticals Inc.
Published: 2026-03-20 11:55 EST
Original Source URL: https://investors.milestonepharma.com
## Summary

FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVT Participants using CARDAMYST in clinical studies were 2x more likely to convert symptomatic PSVT to sinus rhythm and did so more than 3x faster compared with placebo CARDAMYST launch

## Article Body
FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVT Participants using CARDAMYST in clinical studies were 2x more likely to convert symptomatic PSVT to sinus rhythm and did so more than 3x faster compared with placebo CARDAMYST launch
## Recent Company News
- 2026-05-14 12:30 EST — [Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq) — Source: Milestone Pharmaceuticals Inc.
- 2026-05-13 11:11 EST — [Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-announces-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: Milestone Pharmaceuticals Inc.
- 2026-05-06 12:00 EST — [Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-announce-first-quarter-2026-financial-results-on-may-13-2026) — Source: Milestone Pharmaceuticals Inc.
- 2026-04-10 12:00 EST — [Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-announces-reset-psvt-registry-to-generate-real-world-evidence-on-cardamysttm-etripamil-nasal-spray-in-patients-with-psvt) — Source: Milestone Pharmaceuticals Inc.
- 2026-04-07 12:30 EST — [Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Milestone Pharmaceuticals Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)